Download the CCG Board Paper template for MyriBase™ Gel

(Locality name)
Changing from DoublebaseTM Gel to MyriBaseTM Gel
Board paper
Proposal
To change from Doublebase Gel (all pack sizes) to MyriBase Gel.
Case for change
(Locality name) currently spends £x per year on Doublebase Gel. By changing to MyriBase
Gel, (locality name) could save up to £x over a 12 month period. A saving of 20%.
 MyriBase Gel contains exactly the same ingredients as Doublebase Gel1,2
Ingredients
Doublebase
MyriBase








Emulsifier/
Surface Wetting agent
Sorbitan Laurate


pH modifier
Triethanolamine






Emollient
Isopropyl myristate 15%
Emollient
Liquid paraffin 15%
Humectant
Glycerol
Emulsifier
Carbomer
Preservative
Phenoxyethanol
Water base
Purified Water
 MyriBase Gel has exactly the same pack sizes as Doublebase Gel1,2
 All pack sizes of MyriBase Gel cost less than the equivalent pack size of Doublebase Gel3
List price3
Doublebase™
Gel 500g Pump
Doublebase™
Gel 100g Tube
List price3
Percent saving
£5.83
MyriBase™
Gel 500g Pump
£4.66
20%
£2.65
MyriBase™
Gel 100g Tube
(available from
July 2016)
£2.12
20%
 MyriBase Gel is used for the same conditions as Doublebase Gel1,2
 MyriBase Gel has a high quality formulation and packaging
This will make implementation of a formulary change potentially easier and more acceptable
to prescribers and patients.
Risk management
Realisation of cost savings
The cost savings quoted above are for 12 months. A delay in implementation will delay these
savings for the current financial year.
Implementation of formulary change
The following will be used
 Communication to send to practice staff and insertion in the prescribing newsletter
 ScriptSwitch
 Academic detail aid template for the medicines team to use when on practice visits
Continuity of supply
We have been assured of the continuity of supply by Penlan Pharmaceuticals Ltd. who have
their own manufacturing and have supply agreements in place with full-line wholesalers.
References
1. E45 Summary of Product Characteristics. Available at https://www.medicines.org.uk/emc/search. Date accessed May 2016
2. Penlan Pharmaceuticals. MyriBase Gel data sheet February 2016
3. MIMS. Available at http://www.mims.co.uk/drugs. Date accessed May 2016
Product information
Name of Medical Device:
Warnings and precautions:
MyriBase™ Gel
For external use only.
What MyriBase Gel contains:
If the condition worsens on usage or if patients
experience side effects, discontinue use.
The main ingredients are Isopropyl myristate 15%w/w
and Liquid paraffin 15%w/w. The other ingredients are
Glycerol, Carbomer, Sorbitan laurate,
Phenoxyethanol, Triethanolamine and Purified water.
MyriBase Gel is free of fragrances and colourants.
What MyriBase Gel looks like:
Undesirable effects:
Very few side effects have been reported; typically
local skin reactions.
Special precautions for storage:
White gel.
Do not store above 25°C. Use within the date of
expiry.
What MyriBase Gel is used for:
Pack sizes:
To help prevent dry skin conditions, such as eczema,
contact dermatitis, psoriasis, ichthyosis and pruritus.
Available in a 100g tube (£2.12) and a 500g pump
dispenser (£4.66).
Instructions for use:
Legal Status:
Using clean hands apply the gel to the effected skin on
a regular basis and as often as required. Use a few
gentle strokes to smooth the gel across the skin in the
same direction as hair growth. If necessary, allow time
for any excess gel to soak into the skin. Do not rub
vigorously into the skin. If you are applying another
treatment to the same areas of skin as MyriBaseTM
Gel, try to avoid mixing the two products. This can be
achieved by applying the treatments alternately,
leaving sufficient time to allow the previous application
to soak in.
Medical Device, Class I
Contraindications:
28.04.16
CE marking held by:
Penlan Healthcare Ltd. Hanover Place, 8 Church
Road, Tunbridge Wells, Kent, TN1 1JP
Distributed in the UK by:
Penlan Pharmaceuticals Ltd. ONE St. Peter’s Rd,
Maidenhead, SL6 7QU
Date of preparation:
Patients with known hypersensitivity to any of the
ingredients.
Doublebase is a trademark of Dermal Laboratories Limited
MyriBase is a trademark of Penlan Healthcare Limited
PEN/020
Date of preparation June 2016